SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-15-003333
Filing Date
2015-07-14
Accepted
2015-07-14 16:31:15
Documents
16
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tenx_10k.htm 10-K 1554639
2 STOCK OPTION AGREEMENT tenx_ex109.htm EX-10.9 48504
3 SALES AGREEMENT tenx_ex1072.htm EX-10.72 218883
4 SUBSIDIARIES tenx_ex211.htm EX-21.1 3201
5 CONSENT ex_231.htm EX-23.1 3848
6 CERTIFICATION ex_311.htm EX-31.1 11789
7 CERTIFICATION ex_312.htm EX-31.2 12013
8 CERTIFICATION ex_321.htm EX-32.1 8566
9 CERTIFICATION ex_322.htm EX-32.2 9393
10 LOGO logo.jpg GRAPHIC 12532
  Complete submission text file 0001354488-15-003333.txt   6442159

Data Files

Seq Description Document Type Size
11 tenx-20150430.xml EX-101.INS 1229654
12 tenx-20150430.xsd EX-101.SCH 62831
13 tenx-20150430_cal.xml EX-101.CAL 53380
14 tenx-20150430_def.xml EX-101.DEF 115430
15 tenx-20150430_lab.xml EX-101.LAB 434426
16 tenx-20150430_pre.xml EX-101.PRE 276219
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34600 | Film No.: 15987627
SIC: 8731 Services-Commercial Physical & Biological Research